Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Mumbai: A retired GlaxoSmithKline (GSK) employee, Ashok Shetty, on Monday reported a home burglary involving the theft of ...

Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

D NA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire board of directors resigned over disagreements with the C ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...